Stagni, V.; Kaminari, A.; Contadini, C.; Barilà , D.; Sessa, R.L.; Sideratou, Z.; Vlahopoulos, S.A.; Tsiourvas, D.
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres. Cancers 2023, 15, 1474.
https://doi.org/10.3390/cancers15051474
AMA Style
Stagni V, Kaminari A, Contadini C, Barilà D, Sessa RL, Sideratou Z, Vlahopoulos SA, Tsiourvas D.
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres. Cancers. 2023; 15(5):1474.
https://doi.org/10.3390/cancers15051474
Chicago/Turabian Style
Stagni, Venturina, Archontia Kaminari, Claudia Contadini, Daniela Barilà , Rosario Luigi Sessa, Zili Sideratou, Spiros A. Vlahopoulos, and Dimitris Tsiourvas.
2023. "A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres" Cancers 15, no. 5: 1474.
https://doi.org/10.3390/cancers15051474
APA Style
Stagni, V., Kaminari, A., Contadini, C., Barilà , D., Sessa, R. L., Sideratou, Z., Vlahopoulos, S. A., & Tsiourvas, D.
(2023). A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres. Cancers, 15(5), 1474.
https://doi.org/10.3390/cancers15051474